Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rotigotine”

98 trials

Showing 20 of 98 results

Early research (Phase 1)Study completedNCT01565018
What this trial is testing

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Who this might be right for
Healthy Volunteers
UCB Pharma 55
Post-approval studies (Phase 4)WithdrawnNCT02138357
What this trial is testing

Butrans for Treatment of Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
Massachusetts General Hospital
Early research (Phase 1)Study completedNCT00881894
What this trial is testing

Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.

Who this might be right for
Healthy
UCB Pharma 52
Not applicableStudy completedNCT00599339
What this trial is testing

Transdermal Rotigotine User Surveillance Study

Who this might be right for
Idiopathic Parkinson Disease
UCB Pharma 2,195
Early research (Phase 1)Ended earlyNCT04183634
What this trial is testing

An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.

Who this might be right for
Parkinson Disease
Sandoz 31
Large-scale testing (Phase 3)Study completedNCT00242008
What this trial is testing

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma
Early research (Phase 1)Study completedNCT01854216
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 26
Not applicableEnded earlyNCT01554306
What this trial is testing

Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease

Who this might be right for
Nocturnal HypokinesiaParkinsons's DiseaseRotigotine
Sleep Medicine Centre Kempenhaeghe 2
Large-scale testing (Phase 3)Looking for participantsNCT06702124
What this trial is testing

Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
I.R.C.C.S. Fondazione Santa Lucia 348
Testing effectiveness (Phase 2)Study completedNCT00464737
What this trial is testing

The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.

Who this might be right for
Fibromyalgia Syndrome
UCB Pharma 230
Post-approval studies (Phase 4)Study completedNCT01744496
What this trial is testing

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

Who this might be right for
Advanced Idiopathic Parkinson's Disease
UCB BIOSCIENCES GmbH 68
Early research (Phase 1)Study completedNCT01761526
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 50
Not applicableStudy completedNCT01330290
What this trial is testing

Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma 148
Not applicableUnknownNCT02100176
What this trial is testing

MIRT and Rotigotine in the Early Stage of PD

Who this might be right for
Parkinson's Disease
Ospedale Generale Di Zona Moriggia-Pelascini 40
Early research (Phase 1)Study completedNCT01338896
What this trial is testing

Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations

Who this might be right for
Parkinson's Disease
UCB Pharma 56
Post-approval studies (Phase 4)Study completedNCT01711866
What this trial is testing

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

Who this might be right for
Advanced Idiopathic Parkinson's Disease
UCB BIOSCIENCES GmbH 87
Testing effectiveness (Phase 2)Study completedNCT00663338
What this trial is testing

Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke

Who this might be right for
Right Hemisphere StrokeHemispatial NeglectMotor Deficit
University College, London 20
Early research (Phase 1)Study completedNCT00292227
What this trial is testing

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma 130
Post-approval studies (Phase 4)Study completedNCT01455012
What this trial is testing

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB BIOSCIENCES GmbH 81
Post-approval studies (Phase 4)Study completedNCT00594464
What this trial is testing

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

Who this might be right for
Parkinson's Disease
UCB Pharma 14
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation